| Marianne Raimondo, PHD LICSW | |
|
105 Sockanosset Cross Rd Ste 314, Cranston, RI 02920-5560 | |
| (401) 533-4110 | |
| Not Available |
| Full Name | Marianne Raimondo |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 105 Sockanosset Cross Rd Ste 314, Cranston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023444759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | ISW02341 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marianne Raimondo, PHD LICSW 105 Sockanosset Cross Rd Ste 314, Cranston, RI 02920-5560 Ph: () - | Marianne Raimondo, PHD LICSW 105 Sockanosset Cross Rd Ste 314, Cranston, RI 02920-5560 Ph: (401) 533-4110 |
News Archive
Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.
The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.
A surgical team from the Montefiore Einstein Center for Heart and Vascular Care recently received certification training for implanting the SynCardia Total Artificial Heart, a replacement heart implanted in patients at risk of imminent death from heart failure.
The National Cancer Institute's (NCI) new Provocative Questions research funding program has awarded a prestigious grant to a researcher at Roswell Park Cancer Institute (RPCI) to investigate a promising but neglected or unexplored area of cancer research.
ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentation of favorable clinical findings with SAR3419 (coltuximab ravtansine) from the STARLYTE Phase II trial in diffuse large B-cell lymphoma (DLBCL).
› Verified 3 days ago
Bianca Samantha Ogando, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 989 Reservoir Ave, Cranston, RI 02910 Phone: 401-422-9051 | |
Jessica Lynn Mowry, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 75 Sockanosset Cross Rd Ste 206, Cranston, RI 02920 Phone: 401-477-4224 | |
Sarah Elizabeth Carter, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1090 Cranston St, Cranston, RI 02920 Phone: 401-781-3990 | |
Ms. Judith Payne St. Angelo, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 135 Norwood Ave, Cranston, RI 02905 Phone: 401-784-3530 Fax: 401-784-3549 | |
Hannah J Schilke, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 000-000-0000 | |
Ms. Jane A Vieira-iemma, MSW LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 75 Sockanosset Cross Rd, Suite 208, Cranston, RI 02920 Phone: 401-862-6031 |